Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited)

v3.24.0.1
Condensed Consolidated Statements of Changes in Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2022 $ 2 $ 197,370 $ (184,363) $ (4,312) $ 8,697
Beginning balance, shares at Mar. 31, 2022 3,100,937        
Employee stock-based compensation expense 214 214
Foreign currency translation adjustment (65) (65)
Net loss (887) (887)
Ending balance, value at Jun. 30, 2022 $ 2 197,584 (185,250) (4,377) 7,959
Ending balance, shares at Jun. 30, 2022 3,100,937        
Beginning balance, value at Mar. 31, 2022 $ 2 197,370 (184,363) (4,312) 8,697
Beginning balance, shares at Mar. 31, 2022 3,100,937        
Net loss         (3,843)
Ending balance, value at Dec. 31, 2022 $ 2 197,939 (188,206) (4,176) 5,559
Ending balance, shares at Dec. 31, 2022 3,109,652        
Beginning balance, value at Jun. 30, 2022 $ 2 197,584 (185,250) (4,377) 7,959
Beginning balance, shares at Jun. 30, 2022 3,100,937        
Employee stock-based compensation expense 108 108
Stock based compensation related to issuance of restricted common stock 5 5
Stock based compensation related to issuance of restricted common stock, shares 2,035        
Foreign currency translation adjustment (34) (34)
Net loss (1,017) (1,017)
Ending balance, value at Sep. 30, 2022 $ 2 197,697 (186,267) (4,411) 7,021
Ending balance, shares at Sep. 30, 2022 3,102,972        
Employee stock-based compensation expense 233 233
Stock based compensation related to issuance of restricted common stock 9 9
Stock based compensation related to issuance of restricted common stock, shares 6,680        
Foreign currency translation adjustment 235 235
Net loss (1,939) (1,939)
Ending balance, value at Dec. 31, 2022 $ 2 197,939 (188,206) (4,176) 5,559
Ending balance, shares at Dec. 31, 2022 3,109,652        
Beginning balance, value at Mar. 31, 2023 $ 5 200,904 (189,514) (3,418) 7,977
Beginning balance, shares at Mar. 31, 2023 4,933,550        
Cost in connection with ATM (5) (5)
Employee stock-based compensation expense 177 177
Employee stock-based compensation expenses, shares 208,046        
Foreign currency translation adjustment 511 511
Net loss (1,418) (1,418)
Ending balance, value at Jun. 30, 2023 $ 5 201,076 (190,932) (2,907) 7,242
Ending balance, shares at Jun. 30, 2023 5,141,596        
Beginning balance, value at Mar. 31, 2023 $ 5 200,904 (189,514) (3,418) 7,977
Beginning balance, shares at Mar. 31, 2023 4,933,550        
Net loss         (3,768)
Ending balance, value at Dec. 31, 2023 $ 2 202,795 (193,282) (2,823) 6,692
Ending balance, shares at Dec. 31, 2023 13,684,333        
Beginning balance, value at Jun. 30, 2023 $ 5 201,076 (190,932) (2,907) 7,242
Beginning balance, shares at Jun. 30, 2023 5,141,596        
Adjustment to correct par value $ (4) 4
Employee stock-based compensation expense 130 130
Foreign currency translation adjustment (213) (213)
Net loss (1,484) (1,484)
Employee stock-based compensation expenses, shares 37,737        
Ending balance, value at Sep. 30, 2023 $ 1 201,210 (192,416) (3,120) 5,675
Ending balance, shares at Sep. 30, 2023 5,179,333        
Proceeds from October 30, 2023 offering, net of offering expenses $ 1 1,445 1,446
Employee stock-based compensation expense 140 140
Foreign currency translation adjustment 297 297
Net loss (866) (866)
Employee stock-based compensation expenses, shares 5,000        
Proceeds from October 30, 2023 offering, net of offering expenses, shares 8,500,000        
Ending balance, value at Dec. 31, 2023 $ 2 $ 202,795 $ (193,282) $ (2,823) $ 6,692
Ending balance, shares at Dec. 31, 2023 13,684,333